Johnson Johnson Ownership
| JNJ Stock | USD 160.64 1.00 0.63% |
Shares in Circulation | First Issued 2009-03-31 | Previous Quarter 2.4 B | Current Value 2.4 B | Avarage Shares Outstanding 2.7 B | Quarterly Volatility 98.2 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Johnson |
Johnson Stock Ownership Analysis
About 72.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.89. Johnson Johnson recorded earning per share (EPS) of 6.53. The entity last dividend was issued on the 27th of August 2024. The firm had 2:1 split on the 13th of June 2001. Johnson Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company was founded in 1886 and is based in New Brunswick, New Jersey. Johnson Johnson operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 141700 people. To learn more about Johnson Johnson call Alex Gorsky at 732 524 0400 or check out https://www.jnj.com.Besides selling stocks to institutional investors, Johnson Johnson also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Johnson Johnson's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Johnson Johnson's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Johnson Johnson Quarterly Liabilities And Stockholders Equity |
|
Johnson Johnson Insider Trades History
Less than 1% of Johnson Johnson are currently held by insiders. Unlike Johnson Johnson's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Johnson Johnson's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Johnson Johnson's insider trades
Johnson Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Johnson Johnson is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Johnson Johnson backward and forwards among themselves. Johnson Johnson's institutional investor refers to the entity that pools money to purchase Johnson Johnson's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Legal & General Group Plc | 2024-03-31 | 23.3 M | Bank Of New York Mellon Corp | 2024-03-31 | 22.1 M | T. Rowe Price Associates, Inc. | 2024-03-31 | 21.8 M | Wells Fargo & Co | 2024-03-31 | 18.6 M | Capital Research & Mgmt Co - Division 3 | 2024-03-31 | 17.2 M | Massachusetts Financial Services Company | 2024-03-31 | 16.9 M | Fmr Inc | 2024-03-31 | 16.9 M | Charles Schwab Investment Management Inc | 2024-03-31 | 16.2 M | Amvescap Plc. | 2024-03-31 | 14.3 M | Vanguard Group Inc | 2024-03-31 | 228.9 M | Blackrock Inc | 2024-03-31 | 189.7 M |
Johnson Johnson Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Johnson Johnson insiders, such as employees or executives, is commonly permitted as long as it does not rely on Johnson Johnson's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Johnson Johnson insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ronald Williams over six months ago Acquisition by Ronald Williams of 1428 shares of Johnson Johnson subject to Rule 16b-3 |
Johnson Johnson's latest congressional trading
Congressional trading in companies like Johnson Johnson, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Johnson Johnson by those in governmental positions are based on the same information available to the general public.
| 2024-07-15 | Representative Kevin Hern | Acquired Under $15K | Verify | ||
| 2024-07-10 | Representative Richard W Allen | Acquired $15K to $50K | Verify | ||
| 2024-07-03 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2024-04-12 | Representative Kevin Hern | Acquired Under $15K | Verify | ||
| 2024-04-09 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2024-04-05 | Representative Ro Khanna | Acquired $15K to $50K | Verify | ||
| 2024-03-06 | Representative Ro Khanna | Acquired $15K to $50K | Verify | ||
| 2024-02-06 | Representative Kathy Manning | Acquired Under $15K | Verify | ||
| 2024-02-05 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
| 2024-01-17 | Senator Jerry Moran | Acquired Under $15K | Verify | ||
| 2024-01-13 | Representative Kevin Hern | Acquired Under $15K | Verify | ||
| 2023-11-16 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
| 2023-11-15 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
| 2023-10-20 | Senator Pete Ricketts | Acquired $100K to $250K | Verify | ||
| 2023-10-13 | Representative Kevin Hern | Acquired Under $15K | Verify | ||
| 2023-10-05 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2023-10-04 | Representative John Curtis | Acquired Under $15K | Verify | ||
| 2023-10-03 | Senator Sheldon Whitehouse | Acquired Under $15K | Verify | ||
| 2023-10-02 | Senator Sheldon Whitehouse | Acquired Under $15K | Verify | ||
| 2023-09-22 | Senator Dan Sullivan | Acquired Under $15K | Verify | ||
| 2023-09-17 | Senator Dan Sullivan | Acquired Under $15K | Verify | ||
| 2023-08-26 | Representative Lois Frankel | Acquired Under $15K | Verify | ||
| 2023-08-10 | Representative Richard W Allen | Acquired $15K to $50K | Verify | ||
| 2023-07-12 | Representative Kevin Hern | Acquired Under $15K | Verify | ||
| 2023-07-10 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2023-04-10 | Representative Kevin Hern | Acquired Under $15K | Verify | ||
| 2023-03-13 | Representative Lois Frankel | Acquired Under $15K | Verify | ||
| 2023-03-11 | Representative Thomas H Kean | Acquired $15K to $50K | Verify | ||
| 2023-02-11 | Representative Thomas H Kean | Acquired $15K to $50K | Verify | ||
| 2023-01-13 | Representative Kevin Hern | Acquired Under $15K | Verify | ||
| 2022-11-18 | Representative Lois Frankel | Acquired Under $15K | Verify | ||
| 2022-11-13 | Senator Shelley Moore Capito | Acquired Under $15K | Verify | ||
| 2022-11-12 | Senator Shelley Moore Capito | Acquired Under $15K | Verify | ||
| 2022-09-02 | Representative Carol Devine Miller | Acquired $15K to $50K | Verify | ||
| 2022-07-15 | Representative Kevin Hern | Acquired Under $15K | Verify | ||
| 2022-07-11 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2022-07-08 | Representative John Curtis | Acquired Under $15K | Verify | ||
| 2022-06-29 | Representative Diana Harshbarger | Acquired Under $15K | Verify | ||
| 2022-06-09 | Representative Lois Frankel | Acquired Under $15K | Verify | ||
| 2022-04-12 | Representative Kevin Hern | Acquired Under $15K | Verify | ||
| 2022-03-23 | Representative John Curtis | Acquired Under $15K | Verify | ||
| 2022-02-11 | Representative Pete Sessions | Acquired $15K to $50K | Verify | ||
| 2022-02-03 | Senator Thomas R Carper | Acquired Under $15K | Verify | ||
| 2022-02-02 | Senator Thomas R Carper | Acquired Under $15K | Verify | ||
| 2022-01-11 | Representative Kevin Hern | Acquired Under $15K | Verify | ||
| 2021-10-18 | Representative Robert J Wittman | Acquired Under $15K | Verify | ||
| 2021-10-07 | Representative Kevin Hern | Acquired Under $15K | Verify | ||
| 2021-07-15 | Representative Alan S Lowenthal | Acquired Under $15K | Verify | ||
| 2021-06-12 | Representative Richard W Allen | Acquired $15K to $50K | Verify | ||
| 2021-05-06 | Representative Kathy Manning | Acquired Under $15K | Verify | ||
| 2021-02-12 | Representative Austin Scott | Acquired $15K to $50K | Verify | ||
| 2020-12-04 | Representative K Michael Conaway | Acquired $50K to $100K | Verify | ||
| 2020-10-13 | Representative Josh Gottheimer | Acquired Under $15K | Verify | ||
| 2020-09-14 | Representative Carol Devine Miller | Acquired $15K to $50K | Verify | ||
| 2020-09-08 | Representative K Michael Conaway | Acquired $15K to $50K | Verify | ||
| 2020-08-25 | Representative Bob Gibbs | Acquired Under $15K | Verify | ||
| 2020-08-10 | Representative Josh Gottheimer | Acquired Under $15K | Verify | ||
| 2020-07-31 | Representative Bill Pascrell | Acquired $15K to $50K | Verify | ||
| 2020-01-14 | Representative Mike Gallagher | Acquired Under $15K | Verify | ||
| 2020-01-03 | Representative Mikie Sherrill | Acquired Under $15K | Verify | ||
| 2019-12-20 | Representative Lois Frankel | Acquired Under $15K | Verify | ||
| 2019-07-05 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2019-02-14 | Representative John A Yarmuth | Acquired Under $15K | Verify | ||
| 2018-06-26 | Representative Earl Blumenauer | Acquired Under $15K | Verify | ||
| 2018-06-22 | Representative Lois Frankel | Acquired Under $15K | Verify | ||
| 2018-02-01 | Senator David Perdue | Acquired Under $15K | Verify | ||
| 2017-11-07 | Senator Tammy Duckworth | Acquired Under $15K | Verify | ||
| 2017-07-03 | Senator James Inhofe | Acquired $50K to $100K | Verify | ||
| 2016-11-21 | Senator Bill Cassidy | Acquired Under $15K | Verify | ||
| 2014-08-14 | Senator Susan M Collins | Acquired Under $15K | Verify | ||
| 2014-08-13 | Senator Susan M Collins | Acquired Under $15K | Verify |
Johnson Johnson Outstanding Bonds
Johnson Johnson issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Johnson Johnson uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Johnson bonds can be classified according to their maturity, which is the date when Johnson Johnson has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US478111AC18 Corp BondUS478111AC18 | View | |
| US478115AF52 Corp BondUS478115AF52 | View | |
| US478115AB49 Corp BondUS478115AB49 | View | |
| US478165AG84 Corp BondUS478165AG84 | View | |
| US478165AH67 Corp BondUS478165AH67 | View | |
| CVS Health Corp Corp BondUS126650DE72 | View | |
| JOHNSON JOHNSON 695 Corp BondUS478160AJ37 | View | |
| JOHNSON JOHNSON 495 Corp BondUS478160AL82 | View |
Johnson Johnson Corporate Filings
10Q | 25th of July 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 17th of July 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 9th of July 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 25th of June 2024 Other Reports | ViewVerify |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Johnson Stock
When determining whether Johnson Johnson is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Johnson Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Johnson Johnson Stock. Highlighted below are key reports to facilitate an investment decision about Johnson Johnson Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Johnson Johnson. If investors know Johnson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Johnson Johnson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.106 | Dividend Share 4.81 | Earnings Share 6.53 | Revenue Per Share 35.593 | Quarterly Revenue Growth 0.023 |
The market value of Johnson Johnson is measured differently than its book value, which is the value of Johnson that is recorded on the company's balance sheet. Investors also form their own opinion of Johnson Johnson's value that differs from its market value or its book value, called intrinsic value, which is Johnson Johnson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Johnson Johnson's market value can be influenced by many factors that don't directly affect Johnson Johnson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Johnson Johnson's value and its price as these two are different measures arrived at by different means. Investors typically determine if Johnson Johnson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Johnson Johnson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.